Free Trial
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel Free TLM Stock Alerts

Talisman Metals (TLM) Competitors

GBX 7 -0.07 (-0.93%)
As of 08:43 AM Eastern
Compare

TLM vs. FAB, APTA, GENF, RLM, and NSCI

Should you be buying Talisman Metals stock or one of its competitors? The main competitors of Talisman Metals include Fusion Antibodies (FAB), Aptamer Group (APTA), Genflow Biosciences (GENF), Realm Therapeutics (RLM), and NetScientific (NSCI). These companies are all part of the "biotechnology" industry.

How does Talisman Metals compare to Fusion Antibodies?

Talisman Metals (LON:TLM) and Fusion Antibodies (LON:FAB) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends, media sentiment and institutional ownership.

Talisman Metals has a beta of 0.9, meaning that its share price is 10% less volatile than the S&P 500. Comparatively, Fusion Antibodies has a beta of 1.215, meaning that its share price is 22% more volatile than the S&P 500.

Talisman Metals has higher earnings, but lower revenue than Fusion Antibodies. Fusion Antibodies is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Talisman MetalsN/AN/A-£1.35M-£1.32N/A
Fusion Antibodies£1.60M9.50-£4.10M-£1.50N/A

Talisman Metals has a net margin of 0.00% compared to Fusion Antibodies' net margin of -91.92%. Talisman Metals' return on equity of -32.71% beat Fusion Antibodies' return on equity.

Company Net Margins Return on Equity Return on Assets
Talisman MetalsN/A -32.71% 3.70%
Fusion Antibodies -91.92%-210.32%-63.78%

In the previous week, Fusion Antibodies had 2 more articles in the media than Talisman Metals. MarketBeat recorded 2 mentions for Fusion Antibodies and 0 mentions for Talisman Metals. Talisman Metals' average media sentiment score of 0.00 equaled Fusion Antibodies'average media sentiment score.

Company Overall Sentiment
Talisman Metals Neutral
Fusion Antibodies Neutral

1.4% of Talisman Metals shares are held by institutional investors. Comparatively, 7.6% of Fusion Antibodies shares are held by institutional investors. 95.2% of Talisman Metals shares are held by insiders. Comparatively, 5.9% of Fusion Antibodies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Talisman Metals beats Fusion Antibodies on 7 of the 11 factors compared between the two stocks.

How does Talisman Metals compare to Aptamer Group?

Talisman Metals (LON:TLM) and Aptamer Group (LON:APTA) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, media sentiment, institutional ownership, dividends, valuation and risk.

Talisman Metals has a beta of 0.9, indicating that its share price is 10% less volatile than the S&P 500. Comparatively, Aptamer Group has a beta of 0.903, indicating that its share price is 10% less volatile than the S&P 500.

Talisman Metals has higher earnings, but lower revenue than Aptamer Group. Talisman Metals is trading at a lower price-to-earnings ratio than Aptamer Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Talisman MetalsN/AN/A-£1.35M-£1.32N/A
Aptamer Group£1.38M11.68-£14.17M-£0.11N/A

Talisman Metals has a net margin of 0.00% compared to Aptamer Group's net margin of -178.52%. Talisman Metals' return on equity of -32.71% beat Aptamer Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Talisman MetalsN/A -32.71% 3.70%
Aptamer Group -178.52%-135.35%-44.96%

In the previous week, Talisman Metals' average media sentiment score of 0.00 equaled Aptamer Group'saverage media sentiment score.

Company Overall Sentiment
Talisman Metals Neutral
Aptamer Group Neutral

1.4% of Talisman Metals shares are held by institutional investors. Comparatively, 4.1% of Aptamer Group shares are held by institutional investors. 95.2% of Talisman Metals shares are held by company insiders. Comparatively, 8.8% of Aptamer Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Talisman Metals and Aptamer Group tied by winning 5 of the 10 factors compared between the two stocks.

How does Talisman Metals compare to Genflow Biosciences?

Talisman Metals (LON:TLM) and Genflow Biosciences (LON:GENF) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, media sentiment, institutional ownership, dividends, valuation and risk.

Talisman Metals has a beta of 0.9, indicating that its share price is 10% less volatile than the S&P 500. Comparatively, Genflow Biosciences has a beta of 2.108, indicating that its share price is 111% more volatile than the S&P 500.

Genflow Biosciences is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Talisman MetalsN/AN/A-£1.35M-£1.32N/A
Genflow BiosciencesN/AN/A-£1.76M-£0.33N/A

Genflow Biosciences has a net margin of 840.76% compared to Talisman Metals' net margin of 0.00%. Genflow Biosciences' return on equity of 377.33% beat Talisman Metals' return on equity.

Company Net Margins Return on Equity Return on Assets
Talisman MetalsN/A -32.71% 3.70%
Genflow Biosciences 840.76%377.33%-58.66%

In the previous week, Genflow Biosciences had 2 more articles in the media than Talisman Metals. MarketBeat recorded 2 mentions for Genflow Biosciences and 0 mentions for Talisman Metals. Genflow Biosciences' average media sentiment score of 0.38 beat Talisman Metals' score of 0.00 indicating that Genflow Biosciences is being referred to more favorably in the news media.

Company Overall Sentiment
Talisman Metals Neutral
Genflow Biosciences Neutral

1.4% of Talisman Metals shares are held by institutional investors. Comparatively, 0.1% of Genflow Biosciences shares are held by institutional investors. 95.2% of Talisman Metals shares are held by company insiders. Comparatively, 47.5% of Genflow Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Genflow Biosciences beats Talisman Metals on 6 of the 11 factors compared between the two stocks.

How does Talisman Metals compare to Realm Therapeutics?

Realm Therapeutics (LON:RLM) and Talisman Metals (LON:TLM) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, media sentiment, profitability and risk.

1.4% of Talisman Metals shares are owned by institutional investors. 95.2% of Talisman Metals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Realm Therapeutics' return on equity of 0.00% beat Talisman Metals' return on equity.

Company Net Margins Return on Equity Return on Assets
Realm TherapeuticsN/A N/A N/A
Talisman Metals N/A -32.71%3.70%

In the previous week, Realm Therapeutics' average media sentiment score of 0.00 equaled Talisman Metals'average media sentiment score.

Company Overall Sentiment
Realm Therapeutics Neutral
Talisman Metals Neutral

Realm Therapeutics has higher revenue and earnings than Talisman Metals. Talisman Metals is trading at a lower price-to-earnings ratio than Realm Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Realm Therapeutics£501.92K0.00N/A-£17.50N/A
Talisman MetalsN/AN/A-£1.35M-£1.32N/A

Summary

Talisman Metals beats Realm Therapeutics on 4 of the 7 factors compared between the two stocks.

How does Talisman Metals compare to NetScientific?

NetScientific (LON:NSCI) and Talisman Metals (LON:TLM) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, media sentiment, profitability and risk.

Talisman Metals has lower revenue, but higher earnings than NetScientific. Talisman Metals is trading at a lower price-to-earnings ratio than NetScientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NetScientific£1.45M0.00-£2.64M-£0.11N/A
Talisman MetalsN/AN/A-£1.35M-£1.32N/A

NetScientific has a beta of 1.67, suggesting that its share price is 67% more volatile than the S&P 500. Comparatively, Talisman Metals has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500.

14.7% of NetScientific shares are owned by institutional investors. Comparatively, 1.4% of Talisman Metals shares are owned by institutional investors. 42.4% of NetScientific shares are owned by company insiders. Comparatively, 95.2% of Talisman Metals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, NetScientific's average media sentiment score of 0.00 equaled Talisman Metals'average media sentiment score.

Company Overall Sentiment
NetScientific Neutral
Talisman Metals Neutral

Talisman Metals has a net margin of 0.00% compared to NetScientific's net margin of -182.91%. NetScientific's return on equity of -13.70% beat Talisman Metals' return on equity.

Company Net Margins Return on Equity Return on Assets
NetScientific-182.91% -13.70% -9.42%
Talisman Metals N/A -32.71%3.70%

Summary

NetScientific and Talisman Metals tied by winning 5 of the 10 factors compared between the two stocks.

Get Talisman Metals News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLM vs. The Competition

Export
MetricTalisman MetalsBiotechnology IndustryMedical SectorLON Exchange
Market Cap£4.49M£451.91M£6.25B£2.73B
Dividend Yield0.83%3.86%2.74%6.11%
P/E Ratio-5.304.1429.25365.28
Price / SalesN/A6,879.71504.6887,989.37
Price / Cash1.0013.1343.3027.89
Price / Book2.9077.749.677.39
Net Income-£1.35M-£96.07M£3.55B£5.89B
7 Day Performance-6.67%0.71%1.70%0.88%
1 Month PerformanceN/A3.87%5.62%5.27%
1 Year Performance83.01%48.54%34.42%80.43%

Talisman Metals Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLM
Talisman Metals
N/AGBX 7
-0.9%		N/AN/A£4.49MN/AN/A5
FAB
Fusion Antibodies
N/AGBX 14.40
+2.9%		N/AN/A£18.00M£1.60MN/A48
APTA
Aptamer Group
N/AGBX 0.60
-4.0%		N/AN/A£17.56M£1.38MN/A37
GENF
Genflow Biosciences
N/AGBX 2.60
-6.1%		N/AN/A£13.93MN/AN/A5
RLM
Realm Therapeutics
N/AN/AN/AN/A£13.41M£501.92KN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:TLM) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel